+33 (0) 4 76 45 21 20 contact@sb-peptide.com
Select Page

Cyclo(CLLFVY)

Cyclo(CLLFVY) – Cancer Peptides Cyclo(CLLFVY) is a cyclic peptide which binds to the PAS-B domain of HIF-1alpha, thus inhibiting HIF-1 dimerisation and HIF-1 mediated hypoxia signalling.   Technical specification Sequence : Cyclo(CLLFVY) MW : 738.4 g/mol...

PEN-FFW

PEN-FFW – Cancer Peptides Sal-like4 (SALL4) derived peptide able to antagonise the SALL4-NuRD complex in hepatocellular carcinoma, turning SALL4 from a dual transcription repressor-activator to a singular transcription activator. Displays antitumour effects in...

FFW

FFW – Cancer Peptides Sal-like4 (SALL4) derived peptide able to antagonise the SALL4-NuRD complex in hepatocellular carcinoma, turning SALL4 from a dual transcription repressor-activator to a singular transcription activator. Displays antitumour effects in...

YSA acid

YSA acid – Cancer Peptides YSA binds to the extracellular domain of ephrin type-A receptor 2 (EphA2) with high affinity and selectivity. YSA binding activates EphA2 and its tumour suppressing downstream signalling pathways (including inhibition of the PI3K/Akt...

RAGE antagonist peptide

RAGE antagonist peptide – Cancer Peptides RAGE antagonist peptide is an S100P-derived peptide based competitive antagonist for receptor for advanced glycation end product (RAGE). Recent studies have shown it to disrupt the interaction between RAGE and its...